Company Filing History:
2 out of 27 
1 out of 3 Years Active: 2016-2019
Title: The Innovative Contributions of Amir Aharoni
Introduction
Amir Aharoni is a notable inventor based in Beit Kama, Israel. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic proteins. With a total of three patents to his name, Aharoni's work focuses on addressing autoimmune and inflammatory diseases.
Latest Patents
Among his latest patents is a groundbreaking invention titled "Variants of DR3 and use thereof." This patent involves death-domain receptor 3 (DR3) variants that exhibit increased binding affinity to TL1A. The composition derived from these variants has potential applications in treating autoimmune and inflammatory diseases. Another significant patent is related to "IL-17R-ECD mutants and methods of using same." This invention describes a protein with an amino acid sequence that shows at least 97% homology to a specified sequence, which binds to hIL17A, further expanding the therapeutic possibilities in this area.
Career Highlights
Aharoni has worked with esteemed organizations, including the National Institute for Biotechnology in the Negev Ltd. and the National Institute for Biotechnology I. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to innovative research.
Collaborations
Some of Amir Aharoni's notable coworkers include Marianna Zaretzky and Itay Levin. Their collaborative efforts have likely enhanced the research and development of the innovative solutions Aharoni has pioneered.
Conclusion
Amir Aharoni's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in treatments for autoimmune and inflammatory diseases.